Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIyngkaran, Pen
dc.contributor.authorMajoni, Wen
dc.contributor.authorCass, Aen
dc.contributor.authorSanders, Prashanthanen
dc.contributor.authorRonco, Cen
dc.contributor.authorBrady, Sen
dc.contributor.authorKangaharan, Nen
dc.contributor.authorIlton, Men
dc.contributor.authorHare, D Len
dc.contributor.authorThomas, M Cen
dc.identifier.citationHeart, lung & circulation 2015-06; 24(6): 536-43en
dc.description.abstractCongestive Heart Failure (CHF) is an ambulatory care sensitive condition, associated with significant morbidity and mortality, rarely with cure. Outpatient based pharmacological management represents the main and most important aspect of care, and is usually lifelong. This narrative styled opinion review looks at the pharmacological agents recommended in the guidelines in context of the Northern Territory (NT) of Australia. We explore the concept of validity, a term used to describe the basis of standardising a particular trial or study and the population to which it is applicable. We aim to highlight the problems of the current guidelines based approach. We also present alternatives that could utilise the core principles from major trials, while incorporating regional considerations, which could benefit clients living in the NT and remote Australia.en
dc.description.provenanceMade available in DSpace on 2018-05-15T23:01:04Z (GMT). No. of bitstreams: 0 Previous issue date: 2015-06en
dc.subjectHeart Failureen
dc.subjectIndigenous Australiansen
dc.titleNorthern Territory perspectives on heart failure with comorbidities – understanding trial validity and exploring collaborative opportunities to broaden the evidence base.en
dc.typeJournal Articleen
dc.identifier.journaltitleHeart, lung & circulationen
dc.subject.meshCardiovascular Agentsen
dc.subject.meshClinical Trials as Topicen
dc.subject.meshEvidence-Based Medicineen
dc.subject.meshHealth Services, Indigenousen
dc.subject.meshHeart Failureen
dc.subject.meshNorthern Territoryen
dc.subject.meshPractice Guidelines as Topicen
dc.subject.meshRemote Consultationen
dc.subject.meshReproducibility of Resultsen
dc.subject.meshOutcome Assessment (Health Care)en
dc.identifier.affiliationRoyal Darwin Hospital, Flinders University, Darwin Private Hospital, Tiwi, NT 0811. Electronic address:
dc.identifier.affiliationRoyal Darwin Hospital, Department of Nephrology Division of Medicine. Electronic address:
dc.identifier.affiliationMenzies School of Health Research, Casuarina NT 0811. Electronic address:
dc.identifier.affiliationCentre for Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia. Electronic address:
dc.identifier.affiliationDepartment of Nephrology Dialysis & Transplantation, International Renal Research Institute (IRRIV) San Bortolo Hospital, Vicenza, Italy. Electronic address:
dc.identifier.affiliationAlice Springs Hospital, Alice Springs NT 0871. Electronic address:
dc.identifier.affiliationDivision of Medicine, Royal Darwin Hospital, Royal Darwin Hospital, Tiwi, NT 0810. Electronic address:
dc.identifier.affiliationRoyal Darwin Hospital, Royal Darwin Hospital, Tiwi, NT 0810. Electronic address:
dc.identifier.affiliationCoordinator, Cardiovascular Research, University of Melbourne; Director of Heart Failure Services, Austin Health, Vic 3084. Electronic address:
dc.identifier.affiliationBaker IDI Heart and Diabetes Institute, Central Melbourne Victoria 3004, Australia. Electronic address:
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.

Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.